News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex Caitlin E. Cox July 11, 2024
News Daily News Low Bleeding Profile With Asundexian Seen in Pooled Analysis L.A. McKeown February 13, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2024 Shelley Wood February 01, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024
Presentation TCT 2023 TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation Presenter: Taehoon Kim October 25, 2023
Presentation TCT 2023 TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF). Presenter: Hyunki LEE October 25, 2023
Presentation TCT 2023 STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors Presenter: Sanjit Jolly October 25, 2023
Presentation TCT 2023 A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study Presenter: Stefan Verheye October 25, 2023
News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Daily News Label for Impella RP Flex Catheters Recalled to Address Anticoagulant Confusion: FDA Caitlin E. Cox August 18, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Daily News A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4 Shelley Wood April 14, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023